Antibody reactivity of a standardized human serum protein solution against a spectrum of microbial pathogens and toxins: comparison with fresh frozen plasma.
暂无分享,去创建一个
H. Karch | H. Schmidt | W. Struff | O. Thamm | R. Lissner
[1] H. Peter,et al. Comparison of fresh frozen plasma with a standardized serum protein solution following therapeutic plasma exchange in patients with autoimmune disease: a prospective controlled clinical trial. , 2000, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis.
[2] S. Jander,et al. Plasmapheresis in the treatment of Amanita phalloides poisoning: II. A review and recommendations. , 2000, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis.
[3] H. Doerr,et al. Viral Contamination of Plasma Preparations: Determination of the Prevalence of Transfusion-Transmissible Viruses (HAV, HBV, HCV, GB Virus C and HIV) in Plasma Pools and Products , 2000, Transfusion Medicine and Hemotherapy.
[4] A. Arnold,et al. Plasmapheresis with a substitution solution of human serum protein (5%) versus plasmapheresis with a substitution solution of human albumin (5%) in patients suffering from autoimmune diseases. , 1999, Artificial organs.
[5] J. I. Phillips,et al. Chlamydia pneumoniae and atherosclerosis. , 1999, JAMA.
[6] F. Bolgert,et al. Treatment of the adult Guillain-Barré syndrome: indications for plasma exchange. , 1999, Transfusion science.
[7] S. Altekruse,et al. Campylobacter jejuni--an emerging foodborne pathogen. , 1999, Emerging infectious diseases.
[8] A. Rostami,et al. Treatment of Guillain-Barré Syndrome with Intravenous Immunoglobulin , 1998, Neurology.
[9] J. Mestecky,et al. Evaluation of Immunoglobulin A1 (IgA1) Protease and IgA1 Protease-Inhibitory Activity in Human Female Genital Infection with Neisseria gonorrhoeae , 1998, Infection and Immunity.
[10] B. Allos. Association between Campylobacter infection and Guillain-Barré syndrome. , 1997, The Journal of infectious diseases.
[11] M. Kilian,et al. Inhibition of Prevotella and Capnocytophaga immunoglobulin A1 proteases by human serum , 1997, Clinical and diagnostic laboratory immunology.
[12] H. Karch,et al. Bactericidal properties of Campylobacter jejuni-specific immunoglobulin M antibodies in commercial immunoglobulin preparations , 1995, Antimicrobial agents and chemotherapy.
[13] J. Saurat,et al. Characterization of two post-translationally processed forms of human serum retinol-binding protein: altered ratios in chronic renal failure. , 1995, Journal of lipid research.
[14] T. Obrig,et al. Hemolytic‐uremic syndrome and enterohemorrhagic Escherichia coli , 1994, The Pediatric infectious disease journal.
[15] A. Gratwohl,et al. [Immunoglobulin deficiency after repeated plasmapheresis]. , 1991, Schweizerische medizinische Wochenschrift.
[16] P. Murray,et al. In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis , 1989, Antimicrobial Agents and Chemotherapy.
[17] R. Kotitschke,et al. Serum preserve as a replacement fluid for plasma exchange therapy , 1987 .
[18] M. Petric,et al. Purification and biological properties of Escherichia coli verocytotoxin , 1987 .
[19] H. Harders,et al. Plasmapherese, Immunsuppression und hochdosierte IgG-Gaben bei chronischem Guillain-Barré-Syndrom und Antikörpern gegen peripheres Nervengewebe , 1984 .
[20] A. Plaut,et al. INHIBITION OF BACTERIAL IgA PROTEASES BY HUMAN SECRETORY IgA AND SERUM * , 1983, Annals of the New York Academy of Sciences.
[21] R. Gebhardt. Primary cultures of rat hepatocytes as a model system of canalicular development, biliary secretion, and intrahepatic cholestasis. III. Properties of the biliary transport of immunoglobulin A revealed by immunofluorescence. , 1983, Gastroenterology.
[22] N. Tolbert,et al. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. , 1978, Analytical biochemistry.